These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36201404)

  • 1. Developing advanced therapeutics through the study of naturally occurring immune-mediated ocular disease in domestic animals.
    Gilger BC
    Am J Vet Res; 2022 Oct; 83(11):. PubMed ID: 36201404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subconjunctival bone marrow-derived mesenchymal stem cell therapy as a novel treatment alternative for equine immune-mediated keratitis: A case series.
    Davis AB; Schnabel LV; Gilger BC
    Vet Ophthalmol; 2019 Sep; 22(5):674-682. PubMed ID: 30715781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How study of naturally occurring ocular disease in animals improves ocular health globally.
    Gilger BC
    J Am Vet Med Assoc; 2022 Oct; 260(15):1887-1893. PubMed ID: 36198052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Biologics and Stem Cells in Equine Ophthalmology.
    Gilger BC
    Vet Clin North Am Equine Pract; 2023 Dec; 39(3):541-552. PubMed ID: 37442730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary evaluation of safety and migration of immune activated mesenchymal stromal cells administered by subconjunctival injection for equine recurrent uveitis.
    Cassano JM; Leonard BC; Martins BC; Vapniarsky N; Morgan JT; Dow SW; Wotman KL; Pezzanite LM
    Front Vet Sci; 2023; 10():1293199. PubMed ID: 38162475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approach to Immune-mediated Ocular Diseases.
    Knickelbein KE; Lassaline ME
    Vet Clin North Am Equine Pract; 2024 Aug; 40(2):275-286. PubMed ID: 38806348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser scanning in vivo confocal microscopic characterization of equine immune-mediated keratitis.
    Ledbetter EC; Irby NL
    Vet Ophthalmol; 2020 Jan; 23(1):4-15. PubMed ID: 31050168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of corneal autoantibodies in horses with immune mediated keratitis (IMMK).
    Braus BK; Miller I; Kummer S; Kleinwort KJH; Hirmer S; Hauck SM; McMullen RJ; Kerschbaumer M; Deeg CA
    Vet Immunol Immunopathol; 2017 May; 187():48-54. PubMed ID: 28494929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-mediated keratitis in horses: 19 cases (1998-2004).
    Gilger BC; Michau TM; Salmon JH
    Vet Ophthalmol; 2005; 8(4):233-9. PubMed ID: 16008702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and outcomes of horses presenting with presumed equine immune mediated keratitis to two veterinary hospitals in the United Kingdom and Finland: 94 cases (2009-2021).
    Preston JF; Mustikka MP; Priestnall SL; Dunkel B; Fischer MC
    Equine Vet J; 2024 Aug; ():. PubMed ID: 39183684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lens-induced uveitis (endophthalmitis phakoanaphylactica) in domestic animals].
    Pfleghaar S; Schäffer EH
    Tierarztl Prax; 1992 Feb; 20(1):7-18. PubMed ID: 1509484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro.
    Saldinger LK; Nelson SG; Bellone RR; Lassaline M; Mack M; Walker NJ; Borjesson DL
    Vet Ophthalmol; 2020 Jan; 23(1):160-170. PubMed ID: 31441218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologically mediated ocular disease in the horse.
    Hines MT
    Vet Clin North Am Large Anim Pract; 1984 Nov; 6(3):501-12. PubMed ID: 6393544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Relevant Models for Ocular Inflammatory Diseases.
    Gilger BC
    ILAR J; 2018 Dec; 59(3):352-362. PubMed ID: 29474707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy.
    Crabtree E; Uribe K; Smith SM; Roberts D; Salmon JH; Bower JJ; Song L; Bastola P; Hirsch ML; Gilger BC
    PLoS One; 2022; 17(8):e0270972. PubMed ID: 35980983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices.
    Gilger BC; Stoppini R; Wilkie DA; Clode AB; Pinto NH; Hempstead J; Gerding J; Salmon JH
    Vet Ophthalmol; 2014 Jul; 17 Suppl 1():23-30. PubMed ID: 23910236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical and immunopathologic characterization of superficial stromal immune-mediated keratitis in horses.
    Pate DO; Clode AB; Olivry T; Cullen JM; Salmon JH; Gilger BC
    Am J Vet Res; 2012 Jul; 73(7):1067-73. PubMed ID: 22738059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equine recurrent uveitis: the viewpoint from the USA.
    Gilger BC
    Equine Vet J Suppl; 2010 Mar; (37):57-61. PubMed ID: 20939168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivirus-mediated IL-10-expressing Bone Marrow Mesenchymal Stem Cells promote corneal allograft survival
    Lu X; Ru Y; Chu C; Lv Y; Gao Y; Jia Z; Huang Y; Zhang Y; Zhao S
    Theranostics; 2020; 10(18):8446-8467. PubMed ID: 32724480
    [No Abstract]   [Full Text] [Related]  

  • 20. Suspected malignant transformation of B lymphocytes in the equine cornea from immune-mediated keratitis.
    Vallone LV; Neaderland MH; Ledbetter EC; Dubielzig RR
    Vet Ophthalmol; 2016 Mar; 19(2):172-9. PubMed ID: 25919039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.